S-Oil Corp (010950)
Korea Exchange · Korea · prices in KRW · close of 27 Oct 2026
Key indicators
| Last close | KRW 126,400.00 |
|---|---|
| 52-week range | 70,700.00 – 177,100.00 |
| Return, 1 month / 3 months | −18.8% / −6.8% |
| Return, 1 year / 3 years | +72.1% / +90.8% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 33 |
| Volatility (1 year) | 65.8% |
| Worst drawdown (1 year) | -33.8% |
| Average daily value traded | 57,713.78M KRW |
| Dividend yield | 0.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
S-Oil Corp is a Korean refining and petrochemical company based in Seoul, with its main refinery and chemical plants located in Ulsan. It refines crude oil into fuels such as gasoline, diesel and jet fuel, and it also makes petrochemical products including aromatics and olefins that serve industrial customers. The company supplies fuel and chemical materials to customers in Korea and in export markets, and it operates a network of service stations under its own brand.
The shares are listed on the Korea Exchange in Korea under the code 010950, and the price on this page is in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
S-Oil Corp (010950) trades on the Korea Exchange in Korea. It last closed at KRW 126,400.00 on 27 October 2026.
Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 97 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 72.1% and over the last three months it fell 6.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 88 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 3.7% | ||
| From 52-week high | -25.9% | ||
| Momentum | 79 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | -6.8% | ||
| 6-month return | 10.2% | ||
| 12-month return, skipping the last month | 111.8% | ||
| Stability (higher is calmer) | 51 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 65.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -33.8% | ||
| Liquidity | 94 · Strong | Trades actively. | |
| Average daily value traded | 57,713.78M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 32 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.9% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −12.2% |
|---|---|
| 1 month | −18.8% |
| 3 months | −6.8% |
| 6 months | +10.2% |
| 1 year | +72.1% |
| 3 years | +90.8% |
| 5 years | +34.4% |
Signals
| 50-day / 200-day average | 150,848.46 / 121,917.83 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 9,741.70 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Aug 2026 | KRW 800.0000 |
| 3 Apr 2026 | KRW 330.0000 |
| 14 Aug 2024 | KRW 125.0000 |
| 27 Dec 2023 | KRW 1,500.0000 |
| 29 Jun 2023 | KRW 200.0000 |
| 28 Dec 2022 | KRW 3,000.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.